Warren Averett Asset Management, LLC Gilead Sciences, Inc. Transaction History
Warren Averett Asset Management, LLC
- $6.36 Billion
- Q4 2024
A detailed history of Warren Averett Asset Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Warren Averett Asset Management, LLC holds 29,181 shares of GILD stock, worth $3.25 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
29,181
Previous 26,861
8.64%
Holding current value
$3.25 Million
Previous $2.25 Million
19.72%
% of portfolio
0.04%
Previous 0.04%
Shares
12 transactions
Others Institutions Holding GILD
# of Institutions
2,092Shares Held
1.02BCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$13.5 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.9 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$8 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.73 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.46 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $140B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...